Abstract
The etiology for many of the alterations that occur in the sepsis syndrome have confounded researchers for years. Despite the great strides we have made in evaluating the role of the coagulation, complement, arachidonic acid, and other systems in the sepsis syndrome, we have not been able to define clearly the initiating event. Without a clearer understanding of the pathophysiologic mechanisms causing the changes in the sepsis syndrome, it may be unrealistic to expect major advances in improving survival with our current therapies. The present chapter will summarize some of the animal and human data concerning the use of nonsteroidal antiinflammatory agents (NSAIA) and corticosteroids in the sepsis syndrome. We have defined the sepsis syndrome as a spectrum of disease from early sepsis (a systemic response to infection) to septic shock. A more detailed review of the subject can be found elsewhere [1, 2].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Schein RMH, Sprung CL (1986) The use of corticosteroids in the sepsis syndrome. Society of Critical Care Medicine, Fullerton, vol 7, p 131
Schein RMH, Long WM, Sprung CL (1986) Controversies in the management of sepsis and septic shock: corticosteroids, naloxone and nonsteroidal antiinflammatory agents. In: Sib-bald WJ, Sprung CL (eds) New horizons — perspectives on sepsis and septic shock. Society of Critical Care Medicine, Fullerton, p 339
Hinshaw LB, Solomon LA, Erdos EG, Reins BJ (1967) Effects of acetylsalicylic acid on the canine response to endotoxin. J Pharmacol Exp Ther 157: 665
Halushka PV, Wise WC, Cook JA (1983) Studies on the beneficial effects of aspirin in endotoxin shock. Am J Med 74 [Suppl]: 91
Fletcher JR, Ramwell PW (1978) E. coli endotoxin shock in the baboon: treatment with lidocaine or indomethacin. Adv Prostaglandin Thromboxane Leukotriene Res 3: 183
Tempel GE, Cook JA, Wise WC, Halushka PV (1982) The improvement in endotoxininduced redistribution of organ blood flow by inhibition of thromboxane and prostaglandin synthesis. Adv Shock Res 7: 209
Fletcher JR, Ramwell PW (1978) E. coli endotoxin shock in the dog: treatment with lidocaine or indomethacin. Br J Pharmacol 64: 185
Wise WC, Cook JA, Eller T, Halushka PV (1980) Ibuprofen improves survival from endotoxic shock in the rat. J Pharmacol Exp Ther 215: 160
Jacobs ER, Soulsby ME, Bone RC, Wilson FJ, Hiller FC (1982) Ibuprofen in canine endotoxin shock. J Clin Invest 70: 536
Bone RC, Jacobs ER (1984) Research on ibuprofen for sepsis and respiratory failure. Am J Med 77 [Suppl]: 114
Fink MP, MacVittie TJ, Casey LC (1984) Inhibition of prostaglandin synthesis restores normal hemodynamics in canine hyperdynamic sepsis. Ann Surg 200: 619
Snapper JR, Hutchinson AA, Ogletree ML, Brigham KL (1983) Effects of cyclooxygenase inhibitors on the alterations in lung mechanics caused by endotoxemia in the unanesthetized sheep. J Clin Invest 72: 63
Smith EF, Tabas JH, Lefer AM (1980) Beneficial actions of imidazole in endotoxin shock. Prostaglandins Leukotrienes Med 4: 215
Almqvist PM, Ekstrom B, Kuenzie M, Haglund U, Schwartz SI (1984) Increased survival of endotoxin-injected dogs treated with methylprednisolone, naloxone and ibuprofen. Circ Shock 14: 129
Wise WC, Halushka PV, Knapp RG, Cook JA (1985) Ibuprofen, methylprednisolone, and gentamicin as conjoint therapy in septic shock. Circ Shock 17: 59
Goldfarb RD, Glenn TM (1983) Regulation of lysosomal membrane stabilization via cyclic nucleotides and prostaglandin: the effects of steroids and indomethacin. In: Lefer AM, Schumer W (eds) Molecular and cellular aspects of shock and trauma. Liss, New York, p 147
Melby J (1970) Pathophysiology of shock. In: Schumer W, Nyhus LM (eds) Corticosteroids in the treatment of shock. University of Illinois Press, Urbana, p 1
Weismann G, Thomas L (1962) Studies on lysosomes. 1. The effect of endotoxin tolerances and cortisone on the release of acid hydrolases from a granular fraction of rabbit liver. J Exp Med 116: 433
Jacob HS, Craddock PR, Hammerschmidt DE et al. (1980) Complement-induced granulocyte aggregation: an unsuspected mechanism of disease. N Engl J Med 302: 789
Sibbald WJ, Anderson RR, Reid B, Holliday RC, Driedger AA (1981) Alveolo-capillary permeability in human septic ARDS: effect of high-dose corticosteroid therapy. Chest 79: 133
Melby JC (1974) Systemic corticosteroid therapy. Pharmacology and endocrinologie considerations. Ann Intern Med 81: 505
Ottoson J, Brandberg A, Erikson B, et al. (1982) Experimental septic shock — effects of corticosteroids. Circ Shock 9: 571
Hinshaw LB, Solomon LA, Freeny PC, et al. (1967) Hemodynamic and survival effects of methylprednisolone in endotoxin shock. Arch Surg 94: 61
White GL, Archer LT, Beller BK, et al. (1980) Increased survival with methylprednisolone treatment in canine endotoxin shock. J Surg Res 25: 357
Hinshaw LB, Archer LT, Beller-Todd BK, et al. (1979) Recovery from lethal E. coli shock in dogs. Surg Gynecol Obstet 149: 545
Hinshaw LB, Archer LT, Beller-Todd BK, et al. (1980) Survival of primates in LD100 septic shock following steroid-antibiotic therapy. J Surg Res 28: 151
Hinshaw LB, Archer LT, Beller-Todd BK, et al. (1981) Survival of primates in lethal septic shock following delayed treatment with steroid. Circ Shock 8: 291
Hinshaw LB, Beller-Todd BK, Archer LT, et al. (1981) Effectiveness of steroid/antibiotic treatment in primates administered LD100 Escherichia coli. Ann Surg 194: 51
Hinshaw LB, Beller-Todd BK, Archer LT (1982) Current management of the septic shock patient: experimental basis for treatment. Circ Shock 9: 543
Weitzman S, Berger S (1974) Clinical trial design in studies of corticosteroids for bacterial infections. Ann Intern Med 81: 36
Kreger BE, Craven DE, McCabe WR (1980) Gram-negative bacteremia IV: re-evaluation of clinical features and treatment in 612 patients. Am J Med 68: 344
Schumer W (1976) Steroids in the treatment of clinical septic shock. Ann Surg 184: 333
Shine KI, Kuhn M, Young LS, et al. (1980) Aspects of the management of shock. Ann Intern Med 93: 723
Blaisdell FW (1981) Controversy in shock research on: the role of steroids in septic shock. Circ Shock 8: 673
Hoffman SL, Punjabi NH, Kumalas S, et al. (1984) Reduction of mortality in chloramphenicol treated severe typhoid fever by high-dose dexamethasone. N Engl J Med 310: 82
Sprung CL, Caralis PV, Marcial E, et al. (1984) The effects of high-dose corticosteroids in patients with septic shock: a prospective, controlled study. N Engl J Med 311: 1137
Hinshaw L, Peduzzi P, Young E, Sprung CL, et al. (1987) The Veterans Administration Systemic Sepsis Cooperative Study Group: effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 317: 659
Bone RC, Fisher CJ, Clemmer TP, et al. (1987) A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317: 653
Weigelt JA, Norcross JF, Borman KR, Synder WH (1985) Early steroid therapy for respiratory failure. Arch Surg 120: 536
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Sprung, C.L., Schein, R.M.H., Long, W.M. (1989). Corticosteroids and Nonsteroidal Anti-inflammatory Agents in the Sepsis Syndrome. In: Reinhart, K., Eyrich, K. (eds) Sepsis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83083-9_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-83083-9_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-83085-3
Online ISBN: 978-3-642-83083-9
eBook Packages: Springer Book Archive